Austar Lifesciences (Austar Lifesciences) Other Net Income (Loss) : $-16.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Austar Lifesciences Other Net Income (Loss)?

Austar Lifesciences's Other Net Income (Loss) for the six months ended in Dec. 2023 was $-16.3 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was $-16.3 Mil.

Austar Lifesciences's quarterly Other Net Income (Loss) increased from Dec. 2022 ($-4.7 Mil) to Jun. 2023 ($0.0 Mil) but then declined from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($-16.3 Mil).

Austar Lifesciences's annual Other Net Income (Loss) declined from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($-4.7 Mil) and declined from Dec. 2022 ($-4.7 Mil) to Dec. 2023 ($-16.3 Mil).

Austar Lifesciences Other Net Income (Loss) Historical Data

The historical data trend for Austar Lifesciences's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Other Net Income (Loss) Chart

Austar Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

-4.72

-16.32

Austar Lifesciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-4.72	-	-16.32

Austar Lifesciences Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-16.3 Mil.

Austar Lifesciences Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences (Austar Lifesciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (OTCPK:AULSF) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

06118:Hong Kong

Address

No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Austar Lifesciences (Austar Lifesciences) Headlines

No Headlines